Aaron Miller, MD Email Aaron Miller
-
- Position
- PROFESSOR | Neurology
-
- Specialty
- Neurology
-
- Language
- English
-
- Hospital Affiliation
- The Mount Sinai Hospital
-
- Phone
- Corinne Goldsmith Dickinson Center for MS 212-241-6854212-241-6854
Aaron Miller, MD, is the Medical Director of the Corinne Goldsmith Dickinson Center for Multiple Sclerosis and a Professor of Neurology at the Icahn School of Medicine at Mount Sinai. He also serves as Vice-Chair for Education in the Department of Neurology. For 23 years prior to becoming Medical Director, he headed the Division of Neurology at Maimonides Medical Center in Brooklyn, New York, where he also served as director of the Multiple Sclerosis Care Center. Dr. Miller served as Chief Medical Officer and Chairman of the Medical Advisory Board of the National Multiple Sclerosis Society (NMSS) October 2002-2009 and currently chairs the National Medical Advisory Board. He also served as the Chairman of the Clinical Advisory Committee of the New York City Chapter of the NMSS from 1991-2004. He formerly served as the Chairman of the Professional Education Committee of the NMSS and is a past president of the Consortium of MS Centers. He was a member of the National Board of the NMSS from 2002-2017. Dr. Miller was the first Chairman of the multiple sclerosis section of the American Academy of Neurology and has participated in numerous clinical trials of new treatments for multiple sclerosis. Dr. Miller is also very active with the American Academy of Neurology for which he served as Editor of Continuum, their bi-monthly continuing education publication from 2003-2012 and now serves as Editor of Continuum Audio. He was Secretary of the AAN Board (2013-2017) and was also a member of the Board from 2009-2013.. From 1997-2003, he served as Co-chairman of the Education Committee and Chairman of the Annual Meeting Subcommittee.
Certifications
Neurology, American Board of Psychiatry and Neurology
American Board of Internal Medicine
Clinical Focus
- Cervical Myelopathy
- Encephalitis
- Leukodystrophy
- Multiple Sclerosis
- Myelitis
- Neuromyelitis Optica
- Neurosarcoidosis
- Optic Neuritis
- Paraplegia
Education
MD, New York University
Residency, Internal Medicine
Jacobi Hospital Center
Residency, Neurology
Bronx Municipal Hospital Center
Language
English
2011
Best Doctors
New York Magazine
1985
Fellow
American Academy of Neurology
1979
Teacher-Investigator Award
NINCDS
1968
Alpha omega alpha
New York University School of Medicine
1964
Phi beta kappa
Mu chapter of Massachusetts, Brandeis University
Database and Registry
New York State Consortium of Multiple Sclerosis Centers (establishing MS registry and database to be used for multiple collaborative projects)
Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintoré M, Traboulsee AL, Trojano M, Uitdehaag BM, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. The Lancet. Neurology 2018 Feb; 17(2).
Miller AE. Oral teriflunomide in the treatment of relapsing forms of multiple sclerosis: clinical evidence and long-term experience. Therapeutic Advances in Neurological Disorders 2017 Dec; 10(12).
Tornatore C, Phillips JT, Khan O, Miller AE, Hughes M. Consensus opinion of US neurologists on practice patterns in RIS, CIS, and RRMS: Evolution of treatment practices. Neurology. Clinical Practice 2016 Aug; 6(4).
Miller AE, Pelletier D. Multiple sclerosis: Rapid diagnosis or right diagnosis?. Neurology 2016 08; 87(7).
Miller A. Paroxysmal Disorders. In: Burks JS, Johnson KP, editors. Multiple Sclerosis. Diagnosis, Medical Management and Rehabilitation. New York, Demos Medical Publishing, Inc.; 2000.
Miller A, Herndon RM. Treatment Issues. In: Kalb RC, editor. Multiple Sclerosis. The questions you have-the answers you need. New York, Demos Medical Publishing, Inc.; 2000.
Miller A, Herndon RM. Clinical Features. In: Cook SD, editor. Handbook of Multiple Sclerosis. New York, Marcel Dekker, Inc.; 2001.
Goodin DS, Reder AT, Bermel RA, Cutter GR, Fox RJ, John GR, Lublin FD, Lucchinetti CF, Miller AE, Pelletier D, Racke MK, Trapp BD, Vartanian T, Waubant E. Relapses in multiple sclerosis: Relationship to disability. Multiple Sclerosis and Related Disorders 2016 Mar; 6.
Miller AE, Cohen BA, Krieger SC, Markowitz CE, Mattson DH, Tselentis HN, Olsson TP, Miller AE, Dive-Pouletty C, Bégo-Le-Bagousse G, Kappos L. Constructing an adaptive care model for the management of disease-related symptoms throughout the course of multiple sclerosis--performance improvement CME. Multiple Sclerosis (Houndmills, Basingstoke, England) 2014 Jan; 20(1).
Sand IK, Krieger S, Farrell C, Miller AE, Mattson DH, Tselentis HN, Olsson TP, Miller AE, Dive-Pouletty C, Bégo-Le-Bagousse G, Kappos L. Diagnostic uncertainty during the transition to secondary progressive multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England) 2014 Feb;.
Miller AE, Wolinsky JS, Kappos L, Comi G, Freedman MS, Olsson TP, Bauer D, Benamor M, Truffinet P, O'Connor PW. Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet. Neurology 2014 Oct; 13(10).
Miller AE, Macdonell R, Comi G, Freedman MS, Kappos L, Mäurer M, Olsson TP, Wolinsky JS, Bozzi S, Dive-Pouletty C, O'Connor PW. Teriflunomide reduces relapses with sequelae and relapses leading to hospitalizations: results from the TOWER study. Journal of neurology 2014 Sep; 261(9).
Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sørensen PS, Thompson AJ, Wolinsky JS, Balcer LJ, Banwell B, Barkhof F, Bebo B, Calabresi PA, Clanet M, Comi G, Fox RJ, Freedman MS, Goodman AD, Inglese M, Kappos L, Kieseier BC, Lincoln JA, Lubetzki C, Miller AE, Montalban X, O'Connor PW, Petkau J, Pozzilli C, Rudick RA, Sormani MP, Stüve O, Waubant E, Polman CH. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology 2014 Jul; 83(3).
Sand IK, Krieger S, Farrell C, Miller AE, Sørensen PS, Thompson AJ, Wolinsky JS, Balcer LJ, Banwell B, Barkhof F, Bebo B, Calabresi PA, Clanet M, Comi G, Fox RJ, Freedman MS, Goodman AD, Inglese M, Kappos L, Kieseier BC, Lincoln JA, Lubetzki C, Miller AE, Montalban X, O'Connor PW, Petkau J, Pozzilli C, Rudick RA, Sormani MP, Stüve O, Waubant E, Polman CH. Diagnostic uncertainty during the transition to secondary progressive multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) 2014 Feb;.
Vermersch P, Czlonkowska A, Grimaldi LM, Confavreux C, Comi G, Kappos L, Olsson TP, Benamor M, Bauer D, Truffinet P, Church M, Miller AE, Wolinsky JS, Freedman MS, O'Connor P, Goodman AD, Inglese M, Kappos L, Kieseier BC, Lincoln JA, Lubetzki C, Miller AE, Montalban X, O'Connor PW, Petkau J, Pozzilli C, Rudick RA, Sormani MP, Stüve O, Waubant E, Polman CH. Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial. Multiple sclerosis (Houndmills, Basingstoke, England) 2014 May; 20(6).
Bauer D, Truffinet P, Church M, Miller AE, Wolinsky JS, Freedman MS, O'Connor P, Goodman AD, Inglese M, Kappos L, Kieseier BC, Lincoln JA, Lubetzki C, Miller AE, Montalban X, O'Connor PW, Petkau J, Pozzilli C, Rudick RA, Sormani MP, Stüve O, Waubant E, Polman CH. Miller A, Bourdette D, Cohen JA, Coyle PK, Lublin F, Paty DW, Rice GP, Weinstock-Guttman B, editors. Multiple Sclerosis. New York, Continuum; 1999. pp1-196.
Miller AE, Cohen BA, Krieger SC, Markowitz CE, Mattson DH, Tselentis HN, Bauer D, Truffinet P, Church M, Miller AE, Wolinsky JS, Freedman MS, O'Connor P, Goodman AD, Inglese M, Kappos L, Kieseier BC, Lincoln JA, Lubetzki C, Miller AE, Montalban X, O'Connor PW, Petkau J, Pozzilli C, Rudick RA, Sormani MP, Stüve O, Waubant E, Polman CH. Constructing an adaptive care model for the management of disease-related symptoms throughout the course of multiple sclerosis--performance improvement CME. Multiple sclerosis (Houndmills, Basingstoke, England) 2014 Jan; 20(1).
O'Connor PW, Lublin FD, Wolinsky JS, Confavreux C, Comi G, Freedman MS, Olsson TP, Miller AE, Dive-Pouletty C, Bégo-Le-Bagousse G, Kappos L, Miller AE, Wolinsky JS, Freedman MS, O'Connor P, Goodman AD, Inglese M, Kappos L, Kieseier BC, Lincoln JA, Lubetzki C, Miller AE, Montalban X, O'Connor PW, Petkau J, Pozzilli C, Rudick RA, Sormani MP, Stüve O, Waubant E, Polman CH. Teriflunomide reduces relapse-related neurological sequelae, hospitalizations and steroid use. Journal of neurology 2013 Oct; 260(10).
Rudick RA, Miller AE, Wolinsky JS, Confavreux C, Comi G, Freedman MS, Olsson TP, Miller AE, Dive-Pouletty C, Bégo-Le-Bagousse G, Kappos L, Miller AE, Wolinsky JS, Freedman MS, O'Connor P. Multiple sclerosis or multiple possibilities: the continuing problem of misdiagnosis. Neurology 2012 Jun; 78(24).
Miller AE, Rhoades RW, Wolinsky JS, Confavreux C, Comi G, Freedman MS, Olsson TP, Miller AE, Dive-Pouletty C, Bégo-Le-Bagousse G, Kappos L, Miller AE, Wolinsky JS, Freedman MS, O'Connor P. Treatment of relapsing-remitting multiple sclerosis: current approaches and unmet needs. Current opinion in neurology 2012 Feb; 25 Suppl.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Miller during 2017 and/or 2018. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting:
- Acorda Therapeutics Inc.
- Biogen Idec
- CVS Caremark
- EMD Serono, Inc. (Merck & Co., Inc.)
- Genzyme Corporation
- Gerson Lehrman Group
- GlaxoSmithKline
- Nuron Biotech Inc.
Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose
- Letters & Sciences, LLC
- The Scienomics Group (Omnicom Group)
Scientific Advisory Board:
- HealthSTAR Communications
- Questcor Pharmaceuticals, Inc.
- sanofi-aventis
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.